US 10011574
Glutaminase inhibitors and method of use
granted A61PA61P35/00A61P37/00
Quick answer
US patent 10011574 (Glutaminase inhibitors and method of use) held by Agios Pharmaceuticals, Inc. expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P35/00, A61P37/00